-
Energy transition: how coal mines could go solar
-
Australian mushroom murder suspect not on trial for lying: defence
-
New Zealand approves medicinal use of 'magic mushrooms'
-
Suspects in Bali murder all Australian, face death penalty: police
-
Taiwan's entrepreneurs in China feel heat from cross-Strait tensions
-
N. Korea to send army builders, deminers to Russia's Kursk
-
Sergio Ramos gives Inter a scare in Club World Cup stalemate
-
Kneecap rapper in court on terror charge over Hezbollah flag
-
Panthers rout Oilers to capture second NHL Stanley Cup in a row
-
Nearly two centuries on, quiet settles on Afghanistan's British Cemetery
-
Iran says hypersonic missiles fired at Israel as Trump demands 'unconditional surrender'
-
Oil stabilises after surge, stocks drop as Mideast crisis fuels jitters
-
Paul Marshall: Britain's anti-woke media baron
-
Inzaghi defends manner of exit from Inter to Saudi club
-
Made in Vietnam: Hanoi cracks down on fake goods as US tariffs loom
-
Longer exposure, more pollen: climate change worsens allergies
-
Sundowns edge Ulsan in front of empty stands at Club World Cup
-
China downplayed nuclear-capable missile test: classified NZ govt papers
-
Canada needs 'bold ambition' to poach top US researchers
-
US Fed set to hold rates steady as it guards against inflation
-
Sean 'Diddy' Combs trial offers fodder for influencers and YouTubers
-
New rules may not change dirty and deadly ship recycling business
-
US judge orders Trump admin to resume issuing passports for trans Americans
-
Bali flights cancelled after Indonesia volcano eruption
-
India, Canada return ambassadors as Carney, Modi look past spat
-
'What are these wars for?': Arab town in Israel shattered by Iran strike
-
Curfew lifted in LA as Trump battles for control of California troops
-
Chapo's ex-lawyer elected Mexican judge
-
Karbon-X Grows Global Reach with EU Allowances Trading Rollout
-
Guardiola says axed Grealish needs to get 'butterflies back in his stomach'
-
Mbappe a doubt for Real's Club World Cup opener
-
Argentine ex-president Kirchner begins six-year term under house arrest
-
G7 minus Trump rallies behind Ukraine as US blocks statement
-
River Plate ease past Urawa to start Club World Cup tilt
-
Levy wants Spurs to be Premier League winners
-
Monahan to step down as PGA Tour commissioner
-
EU chief says pressure off for lower Russia oil price cap
-
France to hold next G7 summit in Evian spa town
-
Alcaraz wins testing Queen's opener, Fritz, Shelton out
-
Argentine ex-president Kirchner to serve prison term at home
-
Iran confronts Trump with toughest choice yet
-
UK MPs vote to decriminalise abortion for women in all cases
-
R. Kelly lawyers allege he was target of 'overdose' plot by prison guards
-
Tom Cruise to receive honorary Oscar in career first
-
Brazil sells rights to oil blocks near Amazon river mouth
-
Organised crime and murder: top Inter and AC Milan ultras imprisoned
-
Dortmund held by Fluminense at Club World Cup
-
Samsonova downs Osaka as Keys crashes out in Berlin
-
Trump says won't kill Iran's Khamenei 'for now' as Israel presses campaign
-
Tanaka and Murao strike more gold for Japan at judo worlds
Featured
Last news

CSPi to Announce Fiscal Second Quarter Results on May 14, 2025
LOWELL, MA / ACCESS Newswire / May 7, 2025 / CSPi (NASDAQ:CSPI), an award-winning provider of security and packet capture products, managed IT and professional services and technology solutions, announced that it will issue its fiscal 2025 second quarter financial results before the open of the market on Wednesday May 14, 2025.

SpaceX gets US approval to launch more Starship flights from Texas
Elon Musk's SpaceX on Tuesday received approval from the US Federal Aviation Administration (FAA) to increase the number of annual Starship rocket launches from five to 25 at its Texas base, marking a major boost for the company's ambitions.

Ryde Reaffirms Commitment to Gig Workers at NTUC May Day Rally, Supporting Inclusive Growth and Fair Work Practices
SINGAPORE, SINGAPORE / ACCESS Newswire / May 6, 2025 / Ryde Group Ltd (NYSE American:RYDE) ("Ryde'' or the "Company"), a technology company with a leading platform for mobility and quick commerce in Singapore, proudly reaffirmed its commitment to gig workers at the NTUC May Day Rally 2025, joining over 1,600 union leaders, tripartite partners, and fellow Singaporeans in support of a more inclusive, resilient workforce.

Netlist Reports First Quarter 2025 Results
IRVINE, CA / ACCESS Newswire / May 6, 2025 / Netlist, Inc. (OTCQB:NLST) today reported financial results for the first quarter ended March 29, 2025.

Eden Radioisotopes and Cross River Infrastructure Partners Sign MOU to Explore Development of a New Generation Medical Radioisotope Reactor in New Brunswick
ALBUQUERQUE, NM AND GREENWICH, CT / ACCESS Newswire / May 6, 2025 / Eden Radioisotopes, LLC ("Eden") and Cross River Infrastructure Partners, LLC ("CRIP") are pleased to announce the execution of a Memorandum of Understanding (MOU) to jointly explore the development of a new nuclear medical radioisotope reactor and hot cell processing facility in the Province of New Brunswick, Canada. This collaboration marks a significant step forward in Canada's efforts to expand its capabilities in nuclear medicine and build a resilient, regionally anchored supply chain for lifesaving radiodiagnostics and radiopharmaceuticals to bolster regional and national healthcare sovereignty by enabling a secure and sustainable supply of critical medical radioisotopes.

Tharimmune Presents Positive Clinical Data Highlighting TH104 Metabolic Profile and Advances Program for Prophylaxis Against Ultrapotent Opioid Exposure Following FDA Feedback
BRIDGEWATER, NEW JERSEY / ACCESS Newswire / May 6, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology released pharmacokinetic and metabolism data from its Phase 1 study of TH104, a buccal film formulation of nalmefene, in healthy subjects. Tharimmune recently highlighted the advancement of TH104 for the proposed indication of temporary prophylaxis against respiratory and/or central nervous system depression in military personnel and chemical incident responders exposed to high-potency opioids, following recent positive feedback from the U.S. Food and Drug Administration (FDA).

OMP Achieves Top Two Rankings in Four Use Cases in the 2025 Gartner Critical Capabilities for Supply Chain Planning Solutions Report
ANTWERPEN, BE / ACCESS Newswire / May 6, 2025 / OMP, a global leader in supply chain planning solutions, has achieved four second-highest scores across five Use Cases, evaluated in the 2025 Gartner® Critical Capabilities for Supply Chain Planning Solutions report. This report, a companion to the Gartner Magic Quadrant™, assesses the vendors of the SCP solutions evaluated in this research.

Upexi Increases Solana Treasury to 201,500 Solana Tokens for $30 Million and Begins to Generate Staking Revenue
Company has over $60 million in cash remaining to invest further in SOLAt current price of SOL and staking yield, Upexi expects to receive approximately $2.4 million in annual staking revenue and $7.0 million once all funds are invested and staked

Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform
Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order

Loar Holdings Inc. Announces Date and Time for First Quarter 2025 Earnings Conference Call
WHITE PLAINS, NY / ACCESS Newswire / May 6, 2025 / Loar Holdings Inc. (NYSE:LOAR), will report Q1 2025 earnings before the market opens on Tuesday, May 13, 2025.

Greenlite Announces Pre-Launch of NLCSwap a Fully U.S. Compliant Decentralized DEX Crypto Exchange
LOS ANGELES, CALIFORNIA / ACCESS Newswire / May 6, 2025 / Greenlite Ventures, Inc. is proud to announce the pre-launch of NLCSwap.com starting in Montana, a revolutionary decentralized cryptocurrency exchange that combines the best of both worlds: the autonomy and security of a decentralized exchange (DEX) with full compliance under U.S. regulations, including FinCEN registration and strict adherence to KYC (Know Your Customer) and AML (Anti-Money Laundering) protocols.

ACCESS Newswire to Host First Quarter Earnings Conference Call on May 13, 2025
RALEIGH, NC / ACCESS Newswire / May 6, 2025 / ACCESS Newswire Inc. (NYSE American:ACCS), an industry-leading communications company, today announced it will host a conference call and live webcast on May 13, 2025, at 9:00am Eastern Time to discuss the results of the first quarter 2025.

Avant Technologies and Partner, Ainnova, Receive FDA Pre-Submission Meeting Date for Company’s Vision AI Platform Technology
LAS VEGAS, NEVADA / ACCESS Newswire / May 6, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that the U.S. Food and Drug Administration (FDA) has scheduled its pre-submission meeting with Ainnova's executives and its CRO, Fortrea, for July 7, 2025, to discuss a range of items related to the Company's planned clinical trial of its Vision AI platform in the early detection of diabetic retinopathy.

Movella Holdings Inc. Announces Completion of Corporate Restructuring
LOS ANGELES, CA / ACCESS Newswire / May 6, 2025 / Movella Holdings Inc. (the "Company") today announced the completion of a restructuring transaction involving its wholly-owned subsidiary, Movella Inc. ("Movella"), and its existing secured lenders.

Thrive in 2025 by Tony Robbins and Dean Graziosi: What It Is, When It Happens, and Who It's For (Guide Released)
IRAEmpire.com has published a detailed review and update on the Thrive in 2025 event for consumers.

eXoZymes Launches Subsidiary, NCTx, to Unlock a Promising Compound for Gut and Liver Health
N-trans-caffeoyltyramine (NCT) is a natural product compound attracting considerable interest from researchers and drug developers for its potential role in healthy liver fat metabolism, gut barrier function, and mitochondrial activity.eXoZymes used its AI-driven development platform to progress from idea to purpose-built subsidiary in less than 3 months and at a fraction of normal SynBio R&D cost.NCTx is scaling up an exozyme biosolution to overcome a longstanding bottleneck in sourcing the NCT compound from nature, where it occurs only in trace amounts.Interesting pre-clinical data point towards Non-Alcoholic Fatty Liver Disease (NAFLD) that affects more than 30% of the global population.Only NCTx can make both the natural product NCT, and a range of very interesting new-to-nature analog versions, expanding the pharma potential.NCT is the first of more "powered by eXoZymes" natural product nutraceuticals, that also have the potential to become pharmaceuticals.

Crexendo Announces Strong First Quarter 2025 Results
PHOENIX, AZ / ACCESS Newswire / May 6, 2025 / Crexendo, Inc. (NASDAQ:CXDO), an award-winning software technology company that is a premier provider of cloud communication platform and services, video collaboration and managed IT services tailored to businesses of all sizes, today announced financial results for the first quarter ended March 31, 2025.

Brazilian ritual root gets second life as potential anti-depressant
Long used in Indigenous Brazilian rituals, the jurema preta plant, which contains a potent psychedelic, is gaining ground as a potential treatment for depression.

Nazi surrender site sets the scene for Wim Wenders short film
Award-winning German director Wim Wenders has revisited the French school where Nazi Germany signed its initial 1945 surrender for a short film released Monday, days before Europe marks 80 years since the end of World War II.

France, EU leaders spearhead effort to lure US scientists
French President Emmanuel Macron and European Commission head Ursula von der Leyen were set on Monday to host a conference in Paris aimed at attracting US researchers ready to relocate because of President Donald Trump's policies.

Global Interactive Technologies, Inc. Receives Compliance Notice from Nasdaq
SEOUL, KOREA / ACCESS Newswire / May 5, 2025 / Global Interactive Technologies, Inc. (NASDAQ:GITS) (the "Company"), announced that on April 30, 2025 the Company received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, based on the April 30, 2025 filing of the Company's Form 10-K for the year ended December 31, 2024, the Company is now in compliance with Nasdaq's listing requirements.

Inovatec Portal Selected as Finalist for Banking Tech Awards USA
Innovative Loan Application Processing Solution is Shortlisted in the "Best Auto and Equipment LendTech" Category

Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards
With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks

Unusual Machines To Report Financial Results for the First Quarter of 2025 and Provide Corporate Update
ORLANDO, FL / ACCESS Newswire / May 5, 2025 / Unusual Machines (NYSE AMERICAN:UMAC), a leading provider of NDAA-compliant drone components, today announced it will host a webcast on Thursday, May 8th at 4:30 p.m. to discuss the Company's operational and financial results for the first quarter ending March 31, 2025. A question-and-answer session will follow management's remarks.

Paragon Consent Revocation Statement
EASTON, PA / ACCESS Newswire / May 5, 2025 / Paragon Technologies, Inc. (OTC PINK:PGNT)

AI Fund Closes Oversubscribed $190 Million Fund II to Co-Found AI Startups
Venture studio expands its mission to work with entrepreneurs to build AI startups, providing hands-on support and early-stage funding to solve real-world challenges.

Paragon Publishes Consent Revocation Statement and Issues Letter to Stockholders
Urges Stockholders to Not Execute Any White Consent Cards

MicroVision To Announce First Quarter 2025 Results on May 12, 2025
REDMOND, WA / ACCESS Newswire / May 5, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announces that it will report its first quarter 2025 results on Monday, May 12, 2025 after the market close.

C2 Blockchain Inc. Launches AI-Powered Crypto Chatbot in Beta, Pioneering New Subscription Revenue Model and Advancing Toward Market Leadership in Web3 Intelligence
MIAMI BEACH, FL / ACCESS Newswire / May 5, 2025 / C2 Blockchain Inc. (OTC PINK:CBLO), a forward-thinking blockchain infrastructure and digital asset strategy company, proudly announces the beta launch of its proprietary AI-powered crypto chatbot - a powerful trading assistant aimed at transforming how individuals and institutions engage with the crypto markets. With this launch, the company not only deepens its technological footprint but also introduces a scalable, recurring subscription-based revenue stream.

Peraso to Announce First Quarter 2025 Financial Results
SAN JOSE, CALIFORNIA / ACCESS Newswire / May 5, 2025 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company"), a pioneer in mmWave wireless technology solutions, today announced the Company will release its first quarter 2025 financial results on Monday, May 12, 2025, after the market close, followed by a conference call at 1:30 p.m. Pacific Time to discuss the Company's results and business outlook.

C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
KALAMAZOO, MI / ACCESS Newswire / May 5, 2025 / C2Dx, a leading medical device company known for acquiring and revitalizing essential, underserved technologies, is proud to announce its rebrand to Everis. This transformation reflects the company's continued commitment to elevating possibilities in healthcare, expanding its focus, and propelling impactful surgical technologies forward.

Unusual Machines, Inc. Announces Pricing of $40.0 Million Confidentially Marketed Public Offering of Common Stock
ORLANDO, FLORIDA / ACCESS Newswire / May 5, 2025 / Unusual Machines, Inc. ("Unusual Machines" or the "Company") (NYSE American:UMAC), a United States based manufacturer and distributor of drone parts announced today the pricing of its confidentially market public offering (the "Offering") of 8,000,000 shares of common stock at a public offering price of $5.00 per share.